Press release
Free for publication on May 24, 2017 at 9am (CEST +1)
Oulu, Finland, May 24, 2017 – Bittium exhibits its innovative products and solutions for neurology at the Second Moscow International Conference "Non-invasive brain stimulation and functional brain mapping” on May 25th – 27th in Moscow, Russia. The main theme of the event is non-invasive brain stimulation methods in clinical practice and basic research. Bittium has over 10 years of experience with applications for neurophysiology during which the company has developed, for example, an electroencephalography (EEG) solution for TMS-EEG (EEG used during Transcranial Magnetic Stimulation) and fMRI-EEG (EEG used during Magnetic Resonance Imaging) applications. The products and solutions presented are NeurOne monitoring solution for neuroscience measurements and BrainStatus compact EEG amplifier.
At the conference Bittium will have a speaking slot in Section C: “How can we improve results of NIBS (Non-invasive Brain Stimulation)?” on day one of the event. The presentation discusses about the Technical aspects of Real-time EEG triggered TMS stimulation. Bittium’s speaker is Simo-Pekka Simonaho, PhD., specialist neuroscience.
Products presented at the conference:
More information on the offering: https://www.bittium.com/products__services/medical
Further information:
Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507
Distribution:
Main media
Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. From November 2016 onwards, Bittium offers its customers also healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2016 was EUR 64.2 million and operating profit was EUR 2.5 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com